ATLE FUND MANAGEMENT AB

PrivateCIK: 1381843
Location

STOCKHOLM, V7

๐Ÿ“‹ What this filing means

ATLE FUND MANAGEMENT AB filed this quarterly 13Fโ€‘HR report disclosing 39 equity positions with a total reported market value of $313.44M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

39
Positions
$313.44M
Total AUM (reported)
4.92M
Total Shares

Allocation by class

TOTAL AUM$313.44M39 positions
COM$257.32M82.1%
SPONSORED ADS$16.54M5.3%
COM NEW$15.28M4.9%
ORDINARY SHARES$6.91M2.2%
SHS$6.78M2.2%
COM PAR $.01$4.85M1.5%
COMMON STOCK$3.43M1.1%

Portfolio Concentration

Top 325.1%4โ€“1027.9%11โ€“2534.0%Rest13.0%TOP 1053.0%0%100%
Top 3$78.78M25.1%
4โ€“10$87.30M27.9%
11โ€“25$106.56M34.0%
Rest$40.81M13.0%

Top 3 weight

25.1%

Top 10 weight

53.0%

Voting Authority Distribution

Total shares with voting rights: 313.44M

Sole

Full voting authority

313.44M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole39
Shared0
Other0
Dominant voting typeSole ยท 100.0% of voting shares
Institutional Holdings39
Rows:

Eli Lilly & Co

SOLE
COM
Shares31.13K
TypeSH
Market value$33.46M
10.67%
Sole
33.46M
Shared
0.00
None
0.00

AbbVie Inc

SOLE
COM
Shares108.18K
TypeSH
Market value$24.72M
7.89%
Sole
24.72M
Shared
0.00
None
0.00

Merck & Co. Inc

SOLE
COM
Shares195.77K
TypeSH
Market value$20.61M
6.57%
Sole
20.61M
Shared
0.00
None
0.00

Thermo Fisher Scientific Corp

SOLE
COM
Shares29.91K
TypeSH
Market value$17.33M
5.53%
Sole
17.33M
Shared
0.00
None
0.00

Neurocrine Biosciences Inc

SOLE
COM
Shares94.80K
TypeSH
Market value$13.44M
4.29%
Sole
13.44M
Shared
0.00
None
0.00

Intuitive Surgical Inc

SOLE
COM NEW
Shares22.32K
TypeSH
Market value$12.64M
4.03%
Sole
12.64M
Shared
0.00
None
0.00

BEONE MEDICINES LTD-ADR

SOLE
SPONSORED ADS
Shares40.43K
TypeSH
Market value$12.28M
3.92%
Sole
12.28M
Shared
0.00
None
0.00

Bridgebio Pharma Inc

SOLE
COM
Shares141.30K
TypeSH
Market value$10.81M
3.45%
Sole
10.81M
Shared
0.00
None
0.00

Vertex Pharmaceuticals Inc

SOLE
COM
Shares22.98K
TypeSH
Market value$10.42M
3.32%
Sole
10.42M
Shared
0.00
None
0.00

Boston Scientific Corp

SOLE
COM
Shares108.68K
TypeSH
Market value$10.36M
3.31%
Sole
10.36M
Shared
0.00
None
0.00

Stryker Corporation

SOLE
COM
Shares26.84K
TypeSH
Market value$9.43M
3.01%
Sole
9.43M
Shared
0.00
None
0.00

CVS HEALTH CORP

SOLE
COM
Shares106.52K
TypeSH
Market value$8.45M
2.70%
Sole
8.45M
Shared
0.00
None
0.00

Krystal Biotech, Inc

SOLE
COM
Shares33.85K
TypeSH
Market value$8.35M
2.66%
Sole
8.35M
Shared
0.00
None
0.00

Cencora Inc

SOLE
COM
Shares23.77K
TypeSH
Market value$8.03M
2.56%
Sole
8.03M
Shared
0.00
None
0.00

IONIS PHARMACEUTICALS INC

SOLE
COM
Shares92.38K
TypeSH
Market value$7.31M
2.33%
Sole
7.31M
Shared
0.00
None
0.00

REVOLUTION Medicines Inc

SOLE
COM
Shares90.18K
TypeSH
Market value$7.18M
2.29%
Sole
7.18M
Shared
0.00
None
0.00

Amgen Inc

SOLE
COM
Shares21.90K
TypeSH
Market value$7.17M
2.29%
Sole
7.17M
Shared
0.00
None
0.00

Mirum Pharmaceuticals Inc

SOLE
COM
Shares89.69K
TypeSH
Market value$7.08M
2.26%
Sole
7.08M
Shared
0.00
None
0.00

INCYTE CORP

SOLE
COM
Shares70.85K
TypeSH
Market value$7.00M
2.23%
Sole
7M
Shared
0.00
None
0.00

NewAmsterdam Pharma Co NV

SOLE
ORDINARY SHARES
Shares197.04K
TypeSH
Market value$6.91M
2.21%
Sole
6.91M
Shared
0.00
None
0.00

Alkermes PLC

SOLE
SHS
Shares242.47K
TypeSH
Market value$6.78M
2.16%
Sole
6.78M
Shared
0.00
None
0.00

iRhythm Technologies Inc

SOLE
COM
Shares37.58K
TypeSH
Market value$6.67M
2.13%
Sole
6.67M
Shared
0.00
None
0.00

Gilead Sciences Inc

SOLE
COM
Shares50.80K
TypeSH
Market value$6.23M
1.99%
Sole
6.23M
Shared
0.00
None
0.00

UFP Technologies Inc

SOLE
COM
Shares22.99K
TypeSH
Market value$5.10M
1.63%
Sole
5.10M
Shared
0.00
None
0.00

INSMED INC

SOLE
COM PAR $.01
Shares27.87K
TypeSH
Market value$4.85M
1.55%
Sole
4.85M
Shared
0.00
None
0.00
Page 1 of 2
ATLE FUND MANAGEMENT AB 13F Holdings โ€” 39 Positions | Finecho